3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Pancreatic Neoplasms
66
Carcinoma, Non-Small-Cell Lung
39
Breast Neoplasms
32
Triple Negative Breast Neoplasms
25
Neoplasm Metastasis
18
Neoplasms
15
Lung Neoplasms
15
Colorectal Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
6
Ovarian Neoplasms
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Head and Neck Neoplasms
5
Gallbladder Neoplasms
5
Fallopian Tube Neoplasms
5
Adenocarcinoma
5
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Pancreatic Ductal
4
Carcinoma
4
Neoplasms by Site
3
Gastrointestinal Neoplasms
3
Endometrial Neoplasms
3
Brain Neoplasms
3
Biliary Tract Neoplasms
3
Vaccinia
2
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Small Cell Lung Carcinoma
2
Interventions
pembrolizumab
3
Carboplatin
3
selpercatinib
2
durvalumab
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
sotorasib
1
repotrectinib
1
pralsetinib
1
ceralasertib
1
Telescopes
1
Radiosurgery
1
Paclitaxel
1
Gemcitabine
1
Gefitinib
1
Erlotinib Hydrochloride
1
Bevacizumab
1
AZD3759
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
130-nm albumin-bound paclitaxel
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts